Xylem Inc. is a global water technology company that designs, manufactures, and services engineered products and solutions across the water cycle. The company addresses customer needs for scarcity, resilience, quality, and affordability in the delivery, treatment, measurement, and use of drinking water, as well as the collection, testing, analysis, and treatment of wastewater. Its core applications include transport and dewatering, process water and wastewater treatment, analytics, smart metering, and digital software solutions. Xylem serves a diverse customer base including water and wastewater utilities, engineering, procurement, and construction firms, farms, mines, power plants, industrial facilities such as food and beverage and pharmaceutical manufacturers, and residential and commercial customers. The company operates through direct sales forces and independent channel partners. Notable technologies include ADI AnMBR and smart sewer solutions. Xylem maintains a substantial global installed base of products and solutions that provides for parts, replacement, and service revenue.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Specialty Industrial Machinery Homepage xylem.com
Sector Industrials IR page xylem.com/en-us/investors
Tags
water treatment, wastewater management, smart metering, pumps, analytics, digital software, utility infrastructure, industrial water solutions, ADI AnMBR, smart sewer
Press page —

Metrics

Valuation  
Market cap $ 20.548B
Market cap (USD) $ 20.548B
P/E 19.82
PEG 0.51
P/BV 2.00
P/S 2.27
P/OCF 16.15
P/FCF 22.31
Dividend yield 1.9%
Turnover / mcap —
Returns  
ROE 8.7%
ROI 7.1%
ROIC 7.3%
Profit margin 10.6%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 39.2%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 23.0%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 36
Quality score 42.1%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 9.035B 8.562B 7.364B 5.294B 4.998B 4.681B 5.002B 4.963B 4.707B 3.771B 3.653B 3.916B 3.837B 3.791B 3.803B 3.202B
Net profit 957M 890M 609M 355M 427M 254M 401M 549M 331M 260M 340M 337M 228M 297M 279M 329M
Free cash flow 910M 942M 566M 388M 330M 641M 613M 349M 516M 373M 347M 297M 198M 284M 323M 301M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price 136.18 116.02 114.36 110.57 119.92 101.79 78.79 66.72 68.2 49.52 36.5 38.07 34.6 27.1 25.69 —
Price performance 12m 0.17 0.01 0.03 -0.08 0.18 0.29 0.18 -0.02 0.38 0.36 -0.04 0.1 0.28 0.06 — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 843M 956M 1.03B 1.04B 923M 953M 1.1B 1.62B 1.67B 1.76B
↳ YoY growth +12.6% +13.4% +7.8% +0.5% -10.9% +3.3% +15.0% +47.5% +3.2% +5.5%
↳ 5y CAGR +2.2% +4.3% +4.8% +6.1% +4.3% +2.5% +2.8% +9.4% +10.0% +13.8%
Borrowings, current (USD) 860M 600M 257M 276M 600M 0.00 0.00 16M 38M 534M
Borrowings, non-current (USD) 2.11B 2.2B 2.05B 2.04B 2.48B 2.44B 1.88B 2.27B 1.98B 1.41B
Lease liabilities (USD) — — 265M 246M 279M 312M 318M 442M 427M 533M
Cash and deposits (USD) 308M 414M 296M 724M 1.88B 1.35B 944M 1.02B 1.12B 1.48B
Intangible assets (USD) 1.2B 1.17B 1.23B 1.17B 1.09B 1.02B 930M 2.53B 2.38B 2.27B
Right-of-use assets (USD) — — 265M 241M 272M 304M 310M 348M 309M 391M
Net debt (borrowings + leases - cash) (USD) 2.66B 2.39B 2.01B 1.84B 1.49B 1.4B 1.25B 1.71B 1.32B 996M
Cash flow detail
Operating cash flow (USD) 497M 686M 586M 839M 824M 538M 596M 837M 1.26B 1.24B
Purchases of property, plant and equipment (USD) -124M -170M -237M -226M -183M -208M -208M -271M -321M -331M
Change in receivables (cash effect) (USD) -6M -79M -103M -23M 109M -70M -192M -87M -107M -55M
Change in inventories (cash effect) (USD) -15M 27M -97M 47M -5M -167M -147M 41M -41M 23M
Change in payables (cash effect) (USD) 61M 50M 51M 29M -39M 81M 117M 22M 64M -22M
Dividends paid (cash effect) (USD) -112M -130M -152M -174M -188M -203M -217M -299M -350M -391M
Share buybacks (cash effect) (USD) -4M -25M -59M -40M -61M -68M -52M -25M -20M -15M
Interest paid (cash effect) (USD) -49M -78M -78M -77M -77M -99M -76M -69M -67M -61M
Income taxes paid (cash effect) (USD) -78M -57M -75M -107M -41M -83M -91M -211M -219M -267M
Share-based compensation (USD) 18M 21M 30M 29M 26M 33M 37M 60M 56M 53M
Operating cash flow before change in receivables (USD) 503M 765M 689M 862M 715M 608M 788M 924M 1.37B 1.3B
Free cash flow (OCF - PPE - intangibles) (USD) 373M 516M 349M 613M 641M 330M 388M 566M 942M 910M
Income detail
Research and development expense (USD) 110M 180M 189M 191M 187M 204M 206M 232M 230M 226M
↳ 5y CAGR +1.9% +11.2% +12.7% +12.9% +14.5% +13.1% +2.7% +4.2% +3.8% +3.9%
Total comprehensive income (USD) 180M 438M 438M 363M 215M 469M 500M 566M 724M 1.2B
Comprehensive income to owners (USD) 180M 438M 440M 362M 216M 469M 500M 566M 724M 1.17B
Reported Feb 23, 2017 Feb 23, 2018 May 2, 2019 Feb 28, 2020 Feb 26, 2021 Feb 25, 2022 Feb 24, 2023 Feb 25, 2026 Feb 25, 2026 Feb 25, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Xylem Inc. — Other Events Bull 3 Bear 0 Capital return

On November 13, 2026, the Board of Directors of Xylem Inc. (the “Company”) approved the adoption of a new share repurchase program. Under the new program, which has no expiration date, the Company is authorized to purchase up to $1.5 billion in shares of the common stock, $0.01 par value, of the Company (“Common Stock”). Repurchases under the new program may be made through open market purchases or otherwise (in compliance with all applicable laws and regulations in effect from time to time), upon such terms and conditions and at such times and in such amounts not in excess of such aggregate amount as the Company deems advisable. The new program does not obligate the Company to acquire any particular amount of Common Stock, and it may be suspended at any time in the Company’s discretion.

301 Water Street SE, Suite 200 Bull 3 Bear 4 Results

Washington, DC 20003

Tel +1.202.869.9150

Contacts: Media Investors

Press Office Greg Giometti

+1 (978) 704-5149 Michael Travers

[email protected] [email protected]

Xylem Reports Third Quarter 2026 Results and Announces

Strategic Actions to Accelerate Growth

•Strong orders and backlog, solid earnings performance and margin expansion reflect operational excellence despite a more cautious spending environment

•Company accelerates transformation strategy, announces intent to divest Applied Water International and Specialty Flow Control; and move to three segment structure in 2027

WASHINGTON, D.C., October 27, 2026 – Xylem Inc. (NYSE: XYL), a leading global water solutions company dedicated to solving the world’s most challenging water issues, today reported third-quarter 2026 results and announced actions to further accelerate its portfolio transformation.

While revenue was impacted by project timing and more cautious spending decisions, strong order activity and solid earnings performance demonstrated the resilience of the business and the benefits of the company’s transformation.

October 27, 2026

  • Strong orders and backlog, solid earnings performance and margin expansion reflect operational excellence despite a more cautious spending environment
  • Company accelerates transformation strategy, announces intent to divest Applied Water International and Specialty Flow Control**; and move to three segment structure in 2027**

WASHINGTON--(BUSINESS WIRE)-- Xylem Inc. (NYSE: XYL), a leading global water solutions company dedicated to solving the world’s most challenging water issues, today reported third-quarter 2026 results and announced actions to further accelerate its portfolio transformation.

While revenue was impacted by project timing and more cautious spending decisions, strong order activity and solid earnings performance demonstrated the resilience of the business and the benefits of the company’s transformation. Xylem also announced its intent to divest Applied Water International and Specialty Flow Control, and beginning in 2027, the alignment of its businesses from four segments to three.

Third Quarter Results

Highlights:

  • Orders of $2.3 billion, up 7% on a reported basis and 10% organically
  • Revenue of $2.2 billion, down 3% on a reported basis and flat organically
  • Earnings per share of $1.25, up 34%; $1.44 on an adjusted basis, up 5%

Third quarter results reflected a mixed operating environment. The company delivered total revenue of $2.2 billion against a dynamic backdrop. Third-quarter earnings per share were up 34 percent on a reported basis and 5 percent on an adjusted basis.

Net income attributable to Xylem for the quarter was $291 million, or $1.25 per share. Net income margin increased 320 basis points to 13.2 percent. These results are primarily driven by strong operational performance and lower loss on sale of businesses, partially offset by increased interest and income tax expense. Adjusted net income attributable to Xylem was $336 million, or $1.44 per share, which excludes purchase accounting intangible amortization, loss on sale of businesses, restructuring and realignment costs, and special charges, including the impact of IEEPA tariff refunds.

Third-quarter adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin was 23.9 percent, reflecting a year-over-year increase of 70 basis points. Productivity savings and strong price realization drove the margin expansion, exceeding the impact of inflation, lower volumes, and mix.

Outlook

Xylem now forecasts full-year 2026 revenue of approximately $8.95 billion, down 1 percent year over year on a reported basis, versus prior guidance of up 2 percent, and flat on an organic basis, versus prior guidance of up 2 to 3 percent.

Full-year 2026 adjusted EBITDA margin is expected to be approximately 23.2 percent, an increase of 100 basis points versus Xylem’s 2025 adjusted results. This results in full-year adjusted earnings per share of $5.40 to $5.45, down from the previous guidance range of $5.55 to $5.70. Full-year free cash flow margin is expected to be approximately 10.2 percent, versus 10.2 to 11.0 percent previously guided.

Further 2026 planning assumptions are included in Xylem’s third-quarter 2026 earnings materials posted at www.xylem.com/investors . Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Supplemental information on Xylem’s third-quarter earnings, as well as definitions of and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors .

Sharpening Xylem’s Focus for Growth

Xylem's planned divestiture of Applied Water International and Specialty Flow Control and its move to a three-segment structure are designed to create a more focused company aligned around customer needs and long-term growth priorities.

The planned divestitures further sharpen Xylem’s focus, enabling the company to direct capital toward the technologies, capabilities and markets that align most closely with its long-term strategy. Xylem is already seeing momentum in high-growth industry verticals, including data centers and microelectronics, reinforcing the opportunity to increase investment and exposure in these markets.

Beginning January 1, 2027, Xylem will align its business into three segments: Treatment and Services, Flow Solutions, and Measurement and Analytics. The new structure brings together complementary technologies and capabilities around the core activities of moving water, treating water, and measuring and optimizing water systems. By bringing together businesses with shared customers, technologies and growth opportunities, Xylem expects to unlock greater value across the portfolio and operate with greater simplicity, speed and accountability. Treatment and Services will be led by Rodney Aulick; Flow Solutions will be led by Joe Johnston; and Measurement and Analytics will be led by Meredith Emmerich.

“We’re moving with urgency to shape Xylem around the markets where our capabilities can deliver the greatest customer value and strongest long-term growth," said Matthew Pine, president and CEO of Xylem. "The resilience we’ve built, evident this quarter, allows us to make those choices deliberately and from a position of strength.”

About Xylem

Xylem (XYL) is a Fortune 500 global water solutions company that empowers customers and communities to build a more water-secure world. Our 22,000 employees delivered revenue of $9 billion in 2025, optimizing water and resource management with innovation and expertise. Join us at www.xylem.com and Let’s Solve Water.

Xylem uses our Investor Relations website, www.xylem.com/investors , as a means of disclosing information which may be of interest or material to our investors and for complying with disclosure obligations under Regulation FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings, public conference calls, webcasts, and social media.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “contemplate,” “predict,” “forecast,” “likely,” “believe,” “target,” “goal,” “objective,” “will,” “could,” “would,” “should,” “potential,” “may” and similar expressions or their negative, may, but are not necessarily to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector demand and spending, interest rates, availability of funding to our customers, timing of customers’ capital spending and project deployments, inflation and governments' related monetary policy in response, and the strength of the real estate markets, on economic activity and our operations; geopolitical matters, including nationalism, protectionism and anti-global sentiment, volatility involving the U.S. and other governments, ongoing, escalation or outbreak of international conflicts, and regulatory, trade protection, economic and other risks associated with our global sales and operations; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, labor shortages, trade agreements, tariffs, and other trade protection measures, and other factors; demand for our products, disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents, data breaches, or other disruptions of information technology systems on which we or our customers rely, or involving our connected products and services; lack of availability or delays in receiving parts and raw materials from our supply chain, including semiconductors or other key components; operational disruptions at our facilities or that of third parties upon which we rely; safe and compliant treatment and handling of water, wastewater and hazardous materials; failure to successfully execute large projects, including as respects performance guarantees and customers’ budgets, timelines and safety requirements; our ability to retain, compete for, and attract leadership, other key talent and labor; defects, security, warranty and liability claims, and recalls related to our products; uncertainty around productivity, simplification, restructuring and realignment actions and related costs and savings; our ability to execute strategic investments for growth and portfolio optimization actions, including acquisitions and divestitures; availability, regulation or interference with radio spectrum used by certain of our products; volatility in served markets or impacts on our business and operations due to weather conditions, volatile weather events, or changing climate patterns; risks related to our sustainability efforts and related disclosures; fluctuations in foreign currency exchange rates; our level of indebtedness, including debt incurred to finance the pending Cornell Pump and Roper Pump acquisition; difficulty predicting our financial results; risk of future impairments to goodwill and other intangible assets; changes in our effective tax rates or tax expenses; failure to comply with, or changes in, laws or regulations, pertaining to our business conduct, operations, products and services, including anti-corruption, artificial intelligence, data privacy and security, trade, competition, the environment, and health and safety; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; matters related to intellectual property infringement or expiration of rights; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).

All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
(in millions, except per share data)
Three Months Nine Months
For the periods ended September 30, 2026 2025 2026 2025
Revenue from products $ 1,807 $ 1,867 $ 5,517 $ 5,487
Revenue from services 394 401 1,145 1,151
Revenue 2,201 2,268 6,662 6,638
Cost of revenue from products 1,026 1,109 3,176 3,279
Cost of revenue from services 268 276 813 816
Cost of revenue 1,294 1,385 3,989 4,095
Gross profit 907 883 2,673 2,543
Selling, general and administrative expenses 458 474 1,433 1,437
Research and development expenses 56 52 171 166
Restructuring and asset impairment charges 8 23 50 70
Operating income 385 334 1,019 870
Interest expense (21 ) (6 ) (32 ) (23 )
Other non-operating income, net 6 6 3 13
Loss on sale of businesses (5 ) (37 ) (17 ) (47 )
Income before taxes 365 297 973 813
Income tax expense (77 ) (71 ) (235 ) (196 )
Net income $ 288 $ 226 $ 738 $ 617
Net loss attributable to non-controlling interests 3 1 9 5
Net income attributable to Xylem $ 291 $ 227 $ 747 $ 622
Earnings per share:
Basic $ 1.25 $ 0.93 $ 3.15 $ 2.56
Diluted $ 1.25 $ 0.93 $ 3.14 $ 2.55
Weighted average number of shares:
Basic 232.7 243.5 237.3 243.3
Diluted 233.0 244.1 237.7 243.9
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in millions)
September 30,2026 December 31,2025
ASSETS
Current assets:
Cash and cash equivalents $ 708 $ 1,479
Receivables, less allowances for discounts, returns and credit losses of $58 and $68 in 2026 and 2025, respectively 1,965 1,759
Inventories 1,052 983
Prepaid and other current assets 227 244
Assets held for sale — 176
Total current assets 3,952 4,641
Property, plant and equipment, net 1,203 1,159
Goodwill 8,524 8,332
Other intangible assets, net 2,220 2,272
Other non-current assets 1,427 1,230
Total assets $ 17,326 $ 17,634
LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 1,055 $ 1,013
Accrued and other current liabilities 1,257 1,237
Short-term borrowings and current maturities of long-term debt 530 534
Liabilities held for sale — 72
Total current liabilities 2,842 2,856
Long-term debt, net 2,365 1,408
Accrued post-retirement benefit obligations 295 317
Deferred income tax liabilities 453 405
Other non-current accrued liabilities 860 899
Total liabilities 6,815 5,885
Redeemable non-controlling interest 239 258
Stockholders’ equity:
Common stock — par value $0.01 per share:
Authorized 750.0 shares, issued 260.3 and 259.9 shares in 2026 and 2025, respectively 3 3
Capital in excess of par value 8,801 8,759
Retained earnings 4,147 3,706
Treasury stock – at cost 30.0 shares and 16.3 shares in 2026 and 2025, respectively (2,375 ) (768 )
Accumulated other comprehensive loss (307 ) (220 )
Total stockholders’ equity 10,269 11,480
Non-controlling interest 3 11
Total equity 10,272 11,491
Total liabilities, redeemable non-controlling interest, and stockholders’ equity $ 17,326 $ 17,634
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in millions)
For the nine months ended September 30, 2026 2025
Operating Activities
Net income $ 738 $ 617
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation 195 201
Amortization 222 231
Share-based compensation 39 37
Restructuring and asset impairment charges 50 70
Loss from sale of businesses 17 47
Other, net (32 ) 3
Payments for restructuring (59 ) (48 )
Changes in assets and liabilities (net of acquisitions):
Changes in receivables (201 ) (113 )
Changes in inventories (72 ) (30 )
Changes in accounts payable 29 (45 )
Changes in accrued and deferred taxes 14 (12 )
Changes in long term receivables (147 ) (108 )
Other, net (64 ) (152 )
Net Cash — Operating activities 729 698
Investing Activities
Capital expenditures (268 ) (248 )
Acquisitions of businesses, net of cash acquired (425 ) (113 )
Proceeds from sale of businesses, net of cash disposed 95 48
Proceeds from the sale of property, plant and equipment 12 15
Cash received from investments 8 5
Cash paid for investments (10 ) (26 )
Cash paid for equity investments (4 ) (5 )
Cash paid for asset acquisition (2 ) (37 )
Cash received from cross-currency swaps 39 31
Other, net 1 1
Net Cash — Investing activities (554 ) (329 )
Financing Activities
Short-term debt issued, net 4 8
Short-term debt repaid (5 ) (7 )
Long-term debt issued, net 990 —
Long-term debt repaid, net (10 ) (60 )
Repurchase of common stock (1,580 ) (14 )
Proceeds from exercise of employee stock options 3 11
Dividends paid (307 ) (293 )
Other, net (30 ) (27 )
Net Cash — Financing activities (935 ) (382 )
Effect of exchange rate changes on cash (23 ) 83
Increase in cash classified within assets held for sale — (11 )
Decrease in cash classified within assets held for sale 12 11
Changes in cash classified within assets held for sale 12 —
Net change in cash and cash equivalents (771 ) 70
Cash and cash equivalents at beginning of year 1,479 1,121
Cash and cash equivalents at end of period $ 708 $ 1,191
Supplemental disclosure of cash flow information:
Cash paid during the year for:
Interest $ 39 $ 43
Income taxes (net of refunds received) $ 221 $ 208
Xylem Inc. Non-GAAP Measures
Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures that we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.
**“Organic revenue" and "Organic orders”**defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense.“Adjusted EBITDA” and**"Adjusted Segment EBITDA"** reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.
"Adjusted EBITDA Margin" and**"Adjusted Segment EBITDA Margin"**defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.
"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income attributable to Xylem and earnings per share attributable to Xylem, adjusted to exclude restructuring and realignment costs, amortization of acquired intangible assets, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.
"Adjusted Operating Margin" and**"Adjusted Segment Operating Margin"** defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.
“Free Cash Flow” defined as net cash from operating activities, less capital expenditures, as reported in the Statement of Cash Flows. Our definition of free cash flow does not consider certain non-discretionary cash payments, such as debt.
"Free Cash Flow Margin" defined as free cash flow, adjusted (as applicable) for significant cash paid or received for non-operational tax, acquisition or divestiture activities; divided by revenue.
**“Realignment costs”**defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
“Special charges" defined as non-recurring costs incurred by the Company, such as those related to acquisitions and integrations, divestitures non-cash impairment charges and other special charges. In 2026, these charges include reductions of expense related to the refunds of certain tariffs previously imposed under the International, Emergency Economic Powers Act ("IEEPA").
**“Tax-related special items"**defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic Orders ($ Millions)
(As Reported) (As Adjusted - Organic)
(A) (B) (C) (D) (E) (F) = B+C+D+E (G) = F/(A-D)
Change % Change Acquisitions Divestitures Change % Change
Orders Orders 2026 v. 2025 2026 v. 2025 Book-to-Bill FX Impact Adj. 2026 v. 2025 Adj. 2026 v. 2025
2026 2025
Nine Months Ended September 30
Xylem Inc. 7,645 6,513 1,132 17 % 115 % (38 ) 102 (115 ) 1,081 17 %
Water Infrastructure 2,019 1,981 38 2 % 105 % (23 ) 12 (47 ) (20 ) (1 %)
Applied Water 1,552 1,419 133 9 % 108 % - 10 (20 ) 123 9 %
Measurement and Control Solutions 1,409 1,285 124 10 % 97 % (4 ) 80 (14 ) 186 15 %
Water Solutions and Services 2,665 1,828 837 46 % 145 % (11 ) - (34 ) 792 43 %
Quarter Ended September 30
Xylem Inc. 2,331 2,181 150 7 % 106 % (11 ) 74 (4 ) 209 10 %
Water Infrastructure 675 683 (8 ) (1 %) 105 % (2 ) 4 (2 ) (8 ) (1 %)
Applied Water 502 445 57 13 % 103 % - 10 - 67 15 %
Measurement and Control Solutions 504 446 58 13 % 116 % (4 ) 60 - 114 30 %
Water Solutions and Services 650 607 43 7 % 103 % (5 ) - (2 ) 36 6 %
Quarter Ended June 30
Xylem Inc. 3,086 2,174 912 42 % 132 % (15 ) 23 (41 ) 879 41 %
Water Infrastructure 669 672 (3 ) (0 %) 98 % (13 ) 3 (13 ) (26 ) (4 %)
Applied Water 538 488 50 10 % 107 % - - (5 ) 45 9 %
Measurement and Control Solutions 430 437 (7 ) (2 %) 85 % - 20 (3 ) 10 2 %
Water Solutions and Services 1,449 577 872 151 % 225 % (2 ) - (20 ) 850 147 %
Quarter Ended March 31
Xylem Inc. 2,228 2,158 70 3 % 105 % (12 ) 5 (70 ) (7 ) (0 %)
Water Infrastructure 675 626 49 8 % 112 % (8 ) 5 (32 ) 14 2 %
Applied Water 512 486 26 5 % 114 % - - (15 ) 11 2 %
Measurement and Control Solutions 475 402 73 18 % 94 % - - (11 ) 62 15 %
Water Solutions and Services 566 644 (78 ) (12 %) 100 % (4 ) - (12 ) (94 ) (15 %)
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic Revenue ($ Millions)
(As Reported - GAAP) (As Adjusted - Organic)
(A) (B) (C) (D) (E) (F) = B+C+D+E (G) = F/(A-D)
Change % Change Acquisitions Divestitures Change % Change
Revenue Revenue 2026 v. 2025 2026 v. 2025 FX Impact Adj. 2026 v. 2025 Adj. 2026 v. 2025
2026 2025
Nine Months Ended September 30
Xylem Inc. 6,662 6,638 24 0 % (29 ) 116 (97 ) 14 0 %
Water Infrastructure 1,931 1,887 44 2 % (8 ) 13 (45 ) 4 0 %
Applied Water 1,438 1,374 64 5 % - 6 (19 ) 51 4 %
Measurement and Control Solutions 1,452 1,552 (100 ) (6 %) (6 ) 97 (14 ) (23 ) (2 %)
Water Solutions and Services 1,841 1,825 16 1 % (15 ) - (19 ) (18 ) (1 %)
Quarter Ended September 30
Xylem Inc. 2,201 2,268 (67 ) (3 %) (17 ) 80 (3 ) (7 ) (0 %)
Water Infrastructure 645 656 (11 ) (2 %) (1 ) 6 (2 ) (8 ) (1 %)
Applied Water 489 456 33 7 % - 6 - 39 9 %
Measurement and Control Solutions 436 522 (86 ) (16 %) (6 ) 68 1 (23 ) (5 %)
Water Solutions and Services 631 634 (3 ) (0 %) (10 ) - (2 ) (15 ) (2 %)
Quarter Ended June 30
Xylem Inc. 2,336 2,301 35 2 % (7 ) 31 (29 ) 30 1 %
Water Infrastructure 683 650 33 5 % (4 ) 2 (14 ) 17 3 %
Applied Water 501 483 18 4 % - - (5 ) 13 3 %
Measurement and Control Solutions 508 540 (32 ) (6 %) - 29 (4 ) (7 ) (1 %)
Water Solutions and Services 644 628 16 3 % (3 ) - (6 ) 7 1 %
Quarter Ended March 31
Xylem Inc. 2,125 2,069 56 3 % (5 ) 5 (65 ) (9 ) (0 %)
Water Infrastructure 603 581 22 4 % (3 ) 5 (29 ) (5 ) (1 %)
Applied Water 448 435 13 3 % - - (14 ) (1 ) (0 %)
Measurement and Control Solutions 508 490 18 4 % - - (11 ) 7 1 %
Water Solutions and Services 566 563 3 1 % (2 ) - (11 ) (10 ) (2 %)
Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
Q3 2026 Q3 2025
As Reported Adjustments Adjusted As Reported Adjustments Adjusted
Total Revenue 2,201 - 2,201 2,268 - 2,268
Operating Income 385 43 a 428 334 95 a 429
Operating Margin 17.5 % 19.4 % 14.7 % 18.9 %
Interest Expense (21 ) - (21 ) (6 ) - (6 )
Other Non-Operating Income (Expense) 6 - 6 6 - 6
Gain/(Loss) From Sale of Businesses (5 ) 5 b - (37 ) 37 b -
Income before Taxes 365 48 413 297 132 429
Provision for Income Taxes (77 ) (3 ) c (80 ) (71 ) (26 ) c (97 )
Net Income 288 45 333 226 106 332
Net Loss Attributable to Non-controlling Interests 3 - 3 1 - 1
Net Income Attributable to Xylem 291 45 336 227 106 333
Diluted Shares 233.0 233.0 244.1 244.1
Diluted EPS $ 1.25 $ 0.19 $ 1.44 $ 0.93 $ 0.44 $ 1.37
a Restructuring & realignment costs: 2026 - $14 million; 2025 - $31 million
Special charges: 2026 - $10 million of acquisition, divestiture & integration costs, offset by $33 million of IEEPA tariff refunds ; 2025 - $9 million of acquisition, divestiture & integration costs
Purchase accounting intangible amortization: 2026 - $52 million; 2025 - $55 million
b Gain/(Loss) from sale of businesses as per income statement for all periods presented
c 2026 - Net tax impact on pre-tax adjustments (notes a and b) of $8 million, offset by $5 million of other tax special expense items; 2025 - Net tax impact on pre-tax adjustments (notes a and b) of $27 million, offset by $1 million of other tax special expense items;
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
2026
Q1 Q2 Q3 Q4 Total
Net Income attributable to Xylem 193 263 291 747
Net Income margin 9.1 % 11.3 % 13.2 % N/A 11.2 %
Depreciation 65 65 65 195
Amortization 75 75 72 222
Interest Expense (Income), net (4 ) 2 15 13
Income Tax Expense 55 103 77 235
EBITDA 384 508 520 - 1,412
EBITDA Margin 18.1 % 21.7 % 23.6 % N/A 21.2 %
Share-based Compensation 13 12 14 39
Restructuring & Realignment 38 13 14 65
Special Charges 10 (3 ) (23 ) (16 )
Loss/(Gain) from sale of businesses (4 ) 16 5 17
Loss attributable to non-controlling interests (4 ) (2 ) (3 ) (9 )
Adjusted EBITDA 437 544 527 - 1,508
Revenue 2,125 2,336 2,201 6,662
Adjusted EBITDA Margin 20.6 % 23.3 % 23.9 % N/A 22.6 %
2025
Q1 Q2 Q3 Q4 Total
Net Income attributable to Xylem 169 226 227 335 957
Net Income margin 8.2 % 9.8 % 10.0 % 14.0 % 10.6 %
Depreciation 68 69 64 66 267
Amortization 77 76 78 77 308
Interest Expense (Income), net - 3 - (1 ) 2
Income Tax Expense 50 75 71 35 231
EBITDA 364 449 440 512 1,765
EBITDA Margin 17.6 % 19.5 % 19.4 % 21.4 % 19.5 %
Share-based Compensation 12 13 12 16 53
Restructuring & Realignment 27 29 30 45 131
Special Charges 12 13 9 2 36
Loss/(Gain) from sale of businesses 10 - 37 (16 ) 31
Loss attributable to non-controlling interests (2 ) (2 ) (1 ) (2 ) (7 )
Adjusted EBITDA 423 502 527 557 2,009
Revenue 2,069 2,301 2,268 2,397 9,035
Adjusted EBITDA Margin 20.4 % 21.8 % 23.2 % 23.2 % 22.2 %

Media
Press Office +1 (978) 704-5149
[email protected]

Investors
Greg Giometti
Michael Travers
[email protected]

Source: Xylem Inc.

Xylem

Find Products

About Xylem

Careers

Resources

Prompts

Xylem Inc. (ticker XYL), listed in United States.

Company History

Date Change Detail
Aug 5, 2011 Renamed ITT WCO, Inc. → XYLEM INC.

ETFs Holding Xylem Inc.

ETF Weight in ETF Shares Market value As of
CTIF 3.95% 82,090 $ 7.77M Nov 18, 2026
LOPP 2.57% 3,543 $ 418.818K Jun 30, 2026
CCSO 2.51% 10,961 $ 1.051M Nov 17, 2026
LBAY 2.44% 4,432 $ 425.162K Nov 17, 2026
HDGE short -1.33% -6,000 $ -567.9K Nov 17, 2026
NVIR 1.22% 600 $ 70.926K Jun 30, 2026
ALRG 1.21% 865 $ 101.179K Jul 31, 2026
DWSH short -0.96% -625 $ -59.156K Nov 17, 2026
ENDW 0.74% 10,665 $ 1.174M Aug 31, 2026
ACLC 0.57% 16,940 $ 1.865M Aug 31, 2026
RCGE 0.45% 4,653 $ 440K Nov 18, 2026
BTAL 0.44% 10,626 $ 1.256M Jun 30, 2026
JSTC 0.43% 13,325 $ 1.278M Nov 17, 2026
SDVD 0.37% 35,792 $ 3.404M Nov 11, 2026
GVLU 0.28% 7,690 $ 737.702K Nov 17, 2026
ESUM 0.27% 4,231 $ 494.9K Jul 31, 2026
IALT 0.21% 171,048 $ 16.409M Nov 16, 2026
AVMC 0.20% 11,437 $ 1.097M Nov 16, 2026
TACU 0.17% 330 $ 31.657K Nov 17, 2026
FTLS short -0.11% -30,938 $ 0.00 Nov 16, 2026
DFUV 0.09% 151,273 $ 14.224M Nov 12, 2026
DFLV 0.09% 69,681 $ 6.552M Nov 12, 2026
IQSZ 0.08% 1,204 $ 140.832K Jul 31, 2026
GSPY 0.08% 5,875 $ 563.589K Nov 17, 2026
UPAR 0.08% 473 $ 45.375K Nov 17, 2026
FELV 0.08% 20,962 $ 2.478M Jun 30, 2026
DXUV 0.07% 46,260 $ 4.35M Nov 12, 2026
DFSU 0.06% 16,516 $ 1.553M Nov 12, 2026
RPAR 0.06% 3,088 $ 296.232K Nov 17, 2026
XMAG 0.05% 1,123 $ 105.596K Nov 13, 2026
DFAC 0.04% 416,684 $ 39.181M Nov 12, 2026
VOXP 0.04% 21 $ 2,456.37 Jul 31, 2026
NTSX 0.04% 4,614 $ 545.421K Jun 30, 2026
DFAU 0.04% 53,210 $ 5.003M Nov 12, 2026
APUE 0.04% 8,512 $ 937.256K Aug 31, 2026
DCOR 0.04% 171,678 $ 16.143M Nov 12, 2026
HCMT 0.03% 1,654 $ 193.468K Jul 31, 2026
GDE 0.03% 1,429 $ 157.347K Aug 31, 2026
DFUS 0.03% 70,832 $ 6.66M Nov 12, 2026
AVSU 0.03% 1,272 $ 122.023K Nov 16, 2026
FMDE 0.03% 17,290 $ 2.044M Jun 30, 2026
MSLC 0.03% 9,293 $ 1.023M Aug 31, 2026
NTSD 0.02% 67 $ 7,920.07 Jun 30, 2026
AVLC 0.02% 3,807 $ 365.206K Nov 16, 2026
THEQ 0.02% 70 $ 6,715.10 Nov 17, 2026
ACVF 0.02% 229 $ 26.786K Jul 31, 2026
AVUS 0.01% 19,479 $ 1.869M Nov 16, 2026
CSHP 0.01% 396 $ 37.988K Nov 16, 2026
EBI 0.01% 359 $ 39.529K Aug 31, 2026
NPFE 0.00% 100 $ 11.697K Jul 31, 2026
ACGR 0.00% 269 $ 29.62K Aug 31, 2026
CORO 0.00% 147 $ 14.128K Nov 16, 2026